Merck Serono S.A. · Geneva Switzerland
Company Description
View Merck Serono S.A. Locations On A US Map
This link will open in a new window
Fertile minds at Merck Serono help people around the world combat infertility. One of the world's top biotechs, Merck Serono focuses on recombinant genetic engineering to develop drugs. The firm also manufactures and markets therapies for neurological, dermatological, metabolic, oncology, cardiovascular, and growth disorders. It is a leader in reproductive health, with flagship drug Gonal-F at the head of its infertility product line. Other key products include beta interferon drug Rebif for the treatment of multiple sclerosis (MS) and colorectal and head/neck cancer treatment Erbitux. The company is a subsidiary of German drugmaker Merck KGaA . To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Merck Serono S.A. Financials
| Company Type | Subsidiary Headquarters |
| Fiscal Year-End | December |
| Annual Sales (mil.) | $1,139.4 |
| Employees | 800 |
Merck Serono S.A. Executives
9 executives listed for Merck Serono S.A.'s Geneva, location.
| Title | Name & Bio | Contact |
| President | Elmar Schnee | Network |
| SEVP Commercial Europe | Roberto Gradnik | Network |
| SEVP Research | Bernhard Kirschbaum | Network |
Competition
Competitive Landscape for Merck Serono S.A.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Merck Serono S.A. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
